Evidence map›Paper›PMID 38172961›Full record

ArticleDiagnostic pathology2024

Ovarian non-gestational placental site trophoblastic tumor with lung metastasis: further evidence for a distinct category of trophoblastic neoplasm.

Maryam Shahi, Levon Katsakhyan, Mark Hopkins, Wendy Allen-Rhoades, Marissa K Cepress, Carrie Langstraat, Michael B Ishitani, Russell Vang, Brigitte M Ronnett, Deyin Xing

Open access · goldAbstract readCase Reports
In one paragraph

Article in Diagnostic pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Maryam Shahi *Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA. Shahi.Maryam@mayo.edu.
Levon KatsakhyanDepartment of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Mark HopkinsDepartment of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.
Wendy Allen-RhoadesDepartment of Pediatrics, Mayo Clinic, Rochester, MN, USA.
Marissa K CepressDepartment of Pediatrics, Mayo Clinic, Rochester, MN, USA.
Carrie LangstraatDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Michael B Ishitani *Department of Pediatric Surgery, Mayo Clinic, Rochester, MN, USA.
Russell VangDepartment of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Brigitte M RonnettDepartment of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Deyin Xing *Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Mayo Clinic in Arizona · USJohns Hopkins University · US

Funding

Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI Zhenkun Lou · 2009 to 2026
$37.0M
NCI NIH HHS P50 CA136393
6 · The paper itself

Abstract

We previously described a series of cases which characterize a distinct group of primary ovarian placental site trophoblastic tumor (PSTT) and epithelioid trophoblastic tumor (ETT) as a non-gestational set consistent with germ cell type/origin. Here we report a new case of ovarian non-gestational PSTT. The patient was a 13 year-old young female admitted for a spontaneous pneumothorax of the left lung. The pathology of lung wedge excision specimen demonstrated metastatic PSTT and ovarian biopsy showed atypical intermediate trophoblastic proliferation which was found to be PSTT in the subsequent salpingo-oophorectomy specimen. In the ovary, the tumor was composed of singly dispersed or small clusters of predominantly mononuclear cells and rare multinucleated cells extensively infiltrating the ovarian parenchyma, tubal mucosa, and paraovarian/paratubal soft tissue. A minor component of mature cystic teratoma (less than 5% of total tumor volume) was present. Immunohistochemically, the neoplastic cells of main tumor were diffusely immunoreactive for hPL, Gata3 and AE1/AE3, and had only rare hCG-positive or p63-positive cells. The morphology and immunohistochemical results support a PSTT. Molecular genotyping revealed an identical genotype pattern between the normal lung tissue and the metastatic PSTT, indicating its non-gestational nature of germ cell type/origin. This case represents the first case of such tumor with distant (lung) metastasis. This case also provides further evidence to support our recommendation that primary ovarian non-gestational intermediate trophoblastic tumors of germ cell type/origin, including PSTT and ETT, should be formally recognized in classification systems.

Indexed as

Gestational Trophoblastic DiseaseLung NeoplasmsTrophoblastic NeoplasmsTrophoblastic Tumor, Placental SiteUterine NeoplasmsAdolescentFemaleHumansOvaryPlacentaPregnancyMolecular genotypingNon-gestational trophoblastic tumorOvarian germ cell tumorPlacental site trophoblastic tumor

Identifiers

PMID38172961
PMCPMC10765900
OpenAlexW4390571433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.